These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21879817)

  • 21. [Minimal ovarian stimulation: certainly less dangerous and probably as efficient].
    Emperaire JC
    Gynecol Obstet Fertil; 2006 Apr; 34(4):354-5. PubMed ID: 16574462
    [No Abstract]   [Full Text] [Related]  

  • 22. GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.
    Humaidan P; Thomsen LH; Alsbjerg B
    Hum Reprod; 2013 Sep; 28(9):2593-4. PubMed ID: 23842562
    [No Abstract]   [Full Text] [Related]  

  • 23. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P; Papanikolaou EG; Tarlatzis BC
    Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reply: GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.
    Ata B; Seyhan A; Polat M; Son WY; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2594-5. PubMed ID: 23842563
    [No Abstract]   [Full Text] [Related]  

  • 25. 'GnRH agonist trigger: looking for the coin under the lamp post?'.
    Kol S
    Hum Reprod; 2006 May; 21(5):1328; author reply 1328-9. PubMed ID: 16611976
    [No Abstract]   [Full Text] [Related]  

  • 26. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
    Fatemi HM; Garcia-Velasco J
    Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
    Antoine JM; Verstraete L
    Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
    [No Abstract]   [Full Text] [Related]  

  • 29. GnRH agonist triggering: recent developments.
    Kol S; Humaidan P
    Reprod Biomed Online; 2013 Mar; 26(3):226-30. PubMed ID: 23337420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
    Sousa M; Cunha M; Teixeira da Silva J; Oliveira C; Silva J; Viana P; Barros A
    Reprod Biol Endocrinol; 2015 Jun; 13():66. PubMed ID: 26100393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'.
    Ling LP; Phoon JW; Lau MS; Chan JK; Viardot-Foucault V; Tan TY; Nadarajah S; Tan HH
    Reprod Biomed Online; 2014 Sep; 29(3):392-4. PubMed ID: 25042608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of ovarian hyperstimulation syndrome.
    Orvieto R
    Fertil Steril; 2012 Jun; 97(6):e29; author reply e30-1. PubMed ID: 22503420
    [No Abstract]   [Full Text] [Related]  

  • 36. Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support.
    Engmann L; Benadiva C
    Fertil Steril; 2012 Mar; 97(3):531-3. PubMed ID: 22245529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH antagonists are safer than agonists: an update of a Cochrane review.
    Al-Inany HG; Youssef MA; Aboulghar M; Broekmans F; Sterrenburg M; Smit J; Abou-Setta AM
    Hum Reprod Update; 2011; 17(4):435. PubMed ID: 21646384
    [No Abstract]   [Full Text] [Related]  

  • 38. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
    Kol S; Itskovitz-Eldor J
    Semin Reprod Med; 2010 Nov; 28(6):500-5. PubMed ID: 21082509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GnRH antagonists in poor responders.
    Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.